- Home
- UTG vs PRCT Comparison
UTG vs PRCT Comparison
Compare UTG & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTG
- PRCT
- Stock Information
- Founded
- UTG 2003
- PRCT 2009
- Country
- UTG United States
- PRCT United States
- Employees
- UTG N/A
- PRCT N/A
- Industry
- UTG Investment Managers
- PRCT Medical Specialities
- Sector
- UTG Finance
- PRCT Health Care
- Exchange
- UTG Nasdaq
- PRCT Nasdaq
- Market Cap
- UTG 2.8B
- PRCT 2.9B
- IPO Year
- UTG N/A
- PRCT 2021
- Fundamental
- Price
- UTG $33.54
- PRCT $53.12
- Analyst Decision
- UTG
- PRCT Strong Buy
- Analyst Count
- UTG 0
- PRCT 7
- Target Price
- UTG N/A
- PRCT $90.00
- AVG Volume (30 Days)
- UTG 317.8K
- PRCT 1.1M
- Earning Date
- UTG 01-01-0001
- PRCT 04-24-2025
- Dividend Yield
- UTG 7.28%
- PRCT N/A
- EPS Growth
- UTG N/A
- PRCT N/A
- EPS
- UTG 9.86
- PRCT N/A
- Revenue
- UTG $96,107,593.00
- PRCT $249,121,000.00
- Revenue This Year
- UTG N/A
- PRCT $46.28
- Revenue Next Year
- UTG N/A
- PRCT $32.67
- P/E Ratio
- UTG $3.20
- PRCT N/A
- Revenue Growth
- UTG 8.35
- PRCT 59.36
- 52 Week Low
- UTG $25.26
- PRCT $47.04
- 52 Week High
- UTG $35.29
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- UTG 64.43
- PRCT 46.17
- Support Level
- UTG $32.86
- PRCT $52.43
- Resistance Level
- UTG $34.05
- PRCT $56.29
- Average True Range (ATR)
- UTG 0.47
- PRCT 2.88
- MACD
- UTG 0.20
- PRCT 0.28
- Stochastic Oscillator
- UTG 84.21
- PRCT 48.53
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.